Asymmetric Opportunities Seen in Biotech Companies: Caliber Financial

The video discusses the biotech sector's volatility and investment opportunities, focusing on how large pharma companies need to replenish their pipelines as marquee drugs go off-patent. It highlights the impact of the trade war on market expectations and the political posturing involved. The video also presents a case study on Acadia Pharmaceuticals, detailing their drug development efforts for Parkinson's disease and other conditions.

What is Acadia's focus in drug development as described in the text?

What potential breakthroughs are Acadia pursuing with their drug Nuplazid?